Current and future nonstimulants in the treatment of pediatric ADHD: Monoamine reuptake inhibitors, receptor modulators, and multimodal agents

Authors

Andrew J Cutler, SUNY Upstate Medical University
Gregory W Mattingly, Washington University School of Medicine in St. Louis
Rakesh Jain, Texas Tech Health Sciences Center School of Medicine - Permian Basin
Welton O'Neal, Supernus Pharmaceuticals

Journal

CNS spectrums

Publication Date

4-1-2022

Volume

27

Issue

2

First Page

199

Last Page

207

Document Type

Open Access Publication

DOI

10.1017/S1092852920001984

Rights and Permissions

Cutler, A., Mattingly, G., Jain, R., & O’Neal, W. (2022). Current and future nonstimulants in the treatment of pediatric ADHD: Monoamine reuptake inhibitors, receptor modulators, and multimodal agents. CNS Spectrums, 27(2), 199-207. doi.org/10.1017/S1092852920001984 This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Cutler, Andrew J; Mattingly, Gregory W; Jain, Rakesh; and O'Neal, Welton, "Current and future nonstimulants in the treatment of pediatric ADHD: Monoamine reuptake inhibitors, receptor modulators, and multimodal agents." CNS spectrums. 27, 2. 199 - 207. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11769